In Brief: Medtronic Wiktor stent
This article was originally published in The Gray Sheet
Medtronic Wiktor stent: High-pressure balloon-expandable coronary stent is anticipated to receive FDA panel review "by the end of this fall," Medtronic Chief Financial Officer Robert Ryan says Sept. 11 at the Dain Bosworth Healthcare Conference in Minneapolis. The exec estimates that the Wiktor holds a 40% market share in Japan and a 25% market share in Europe...
You may also be interested in...
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.